<html>
  <head>
    <meta  content="text/html; charset=windows-1252"  http-equiv="content-type">
    <!-- <script src="//code.jquery.com/jquery-1.12.0.min.js"></script> -->
    <script  src="shared/jquery.js"  type="text/javascript"></script>
    <script  src="shared/shiny.js"  type="text/javascript"></script>
    <link  href="shared/bootstrap/css/bootstrap.min.css"  rel="stylesheet">
    <link  rel="stylesheet"  type="text/css"  href="css/ilincs.css">
    <script>

   $(function(){
     $("#includeNav").load("html/nav.html");
     $("#includeFooter").load("html/footer.html");
   });
   </script>
    <!--Above from the simple About-->
    <!--Below from the description document-->
    <style>
#content {
  margin-left:  40%;
}
#navbar {
  float: left;
  position: fixed;
  width: 20%;
}
</style> <style  type="text/css">.lst-kix_c6mggzy9bkhi-7>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-7}ol.lst-kix_lx3h5q6cjds-3{list-style-type:none}ol.lst-kix_lx3h5q6cjds-2{list-style-type:none}ol.lst-kix_lx3h5q6cjds-5.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-5 0}.lst-kix_qnsw2cr2b80j-8>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-8>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-8}ol.lst-kix_c6mggzy9bkhi-3.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-3 0}.lst-kix_qnsw2cr2b80j-6>li:before{content:"\0025cf  "}.lst-kix_lx3h5q6cjds-8>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-8}.lst-kix_qnsw2cr2b80j-7>li:before{content:"\0025cb  "}.lst-kix_qnsw2cr2b80j-1>li:before{content:"\0025cb  "}ol.lst-kix_ixtk3xu5n7qn-4.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-4 0}.lst-kix_qnsw2cr2b80j-0>li:before{content:"\0025cf  "}.lst-kix_qnsw2cr2b80j-2>li:before{content:"\0025a0  "}.lst-kix_qnsw2cr2b80j-5>li:before{content:"\0025a0  "}.lst-kix_qnsw2cr2b80j-4>li:before{content:"\0025cb  "}.lst-kix_qnsw2cr2b80j-3>li:before{content:"\0025cf  "}ul.lst-kix_jw98yuw3jje1-8{list-style-type:none}ul.lst-kix_jw98yuw3jje1-7{list-style-type:none}ol.lst-kix_lx3h5q6cjds-4.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-4 0}ul.lst-kix_jw98yuw3jje1-6{list-style-type:none}ul.lst-kix_jw98yuw3jje1-5{list-style-type:none}ul.lst-kix_jw98yuw3jje1-4{list-style-type:none}ul.lst-kix_jw98yuw3jje1-3{list-style-type:none}ul.lst-kix_jw98yuw3jje1-2{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-2.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-2 0}ul.lst-kix_jw98yuw3jje1-1{list-style-type:none}ul.lst-kix_jw98yuw3jje1-0{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-2{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-1{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-8.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-8 0}ul.lst-kix_qnsw2cr2b80j-0{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-6{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-5{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-4{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-3{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-8{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-7{list-style-type:none}.lst-kix_c6mggzy9bkhi-5>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-5}.lst-kix_jw98yuw3jje1-0>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-1>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-1}ol.lst-kix_lx3h5q6cjds-8{list-style-type:none}ol.lst-kix_lx3h5q6cjds-7{list-style-type:none}ol.lst-kix_lx3h5q6cjds-6{list-style-type:none}.lst-kix_ixtk3xu5n7qn-4>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-4}ol.lst-kix_lx3h5q6cjds-5{list-style-type:none}.lst-kix_jw98yuw3jje1-1>li:before{content:"\0025cb  "}ol.lst-kix_lx3h5q6cjds-4{list-style-type:none}.lst-kix_jw98yuw3jje1-2>li:before{content:"\0025a0  "}.lst-kix_jw98yuw3jje1-4>li:before{content:"\0025cb  "}.lst-kix_jw98yuw3jje1-3>li:before{content:"\0025cf  "}.lst-kix_lx3h5q6cjds-4>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-4}.lst-kix_cqitspa334da-6>li:before{content:"\0025cf  "}.lst-kix_jw98yuw3jje1-5>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-7.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-7 0}.lst-kix_cqitspa334da-4>li:before{content:"\0025cb  "}.lst-kix_jw98yuw3jje1-7>li:before{content:"\0025cb  "}.lst-kix_c6mggzy9bkhi-0>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-0}ol.lst-kix_ixtk3xu5n7qn-5.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-5 0}.lst-kix_cqitspa334da-2>li:before{content:"\0025a0  "}.lst-kix_k1hefpyt8qdu-1>li:before{content:"\0025cb  "}.lst-kix_lx3h5q6cjds-3>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-3}.lst-kix_ixtk3xu5n7qn-3>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-3}.lst-kix_cqitspa334da-0>li:before{content:"\0025cf  "}.lst-kix_k1hefpyt8qdu-3>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-0>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-0,decimal) ". "}.lst-kix_ixtk3xu5n7qn-2>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-2,lower-roman) ". "}.lst-kix_k1hefpyt8qdu-5>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-4>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-4,
lower-latin) ". "}.lst-kix_lx3h5q6cjds-2>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-2}.lst-kix_lx3h5q6cjds-7>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-7,lower-latin) ". "}.lst-kix_k1hefpyt8qdu-7>li:before{content:"\0025cb  "}.lst-kix_ixtk3xu5n7qn-2>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-2}ul.lst-kix_c6mggzy9bkhi-1{list-style-type:none}.lst-kix_ixtk3xu5n7qn-8>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-8,lower-roman) ". "}.lst-kix_ixtk3xu5n7qn-6>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-6,decimal) ". "}.lst-kix_qkescwycupop-7>li:before{content:"\0025cb  "}.lst-kix_4vw5dpxrimee-5>li:before{content:"\0025a0  "}.lst-kix_qkescwycupop-1>li:before{content:"\0025cb  "}.lst-kix_c6mggzy9bkhi-4>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-4,lower-latin) ". "}.lst-kix_c6mggzy9bkhi-6>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-6,decimal) ". "}.lst-kix_4vw5dpxrimee-3>li:before{content:"\0025cf  "}.lst-kix_4vw5dpxrimee-7>li:before{content:"\0025cb  "}.lst-kix_4vw5dpxrimee-1>li:before{content:"\0025cb  "}.lst-kix_qkescwycupop-5>li:before{content:"\0025a0  "}.lst-kix_c6mggzy9bkhi-0>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-0,decimal) ". "}.lst-kix_c6mggzy9bkhi-2>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-2,lower-roman) ". "}.lst-kix_c6mggzy9bkhi-8>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-8,lower-roman) ". "}ol.lst-kix_ixtk3xu5n7qn-3.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-3 0}.lst-kix_qkescwycupop-3>li:before{content:"\0025cf  "}.lst-kix_9dbpnvhyro1-6>li:before{content:"\0025cf  "}.lst-kix_9dbpnvhyro1-8>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-5.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-5 0}.lst-kix_lx3h5q6cjds-5>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-5,lower-roman) ". "}.lst-kix_lx3h5q6cjds-3>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-3,decimal) ". "}ul.lst-kix_k1hefpyt8qdu-8{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-7{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-2.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-2 0}.lst-kix_lx3h5q6cjds-1>li:before{content:"\0025cb  "}ul.lst-kix_k1hefpyt8qdu-0{list-style-type:none}.lst-kix_4v4tuo10gdxg-7>li:before{content:"\0025cb  "}ul.lst-kix_k1hefpyt8qdu-2{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-1{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-4{list-style-type:none}.lst-kix_4v4tuo10gdxg-5>li:before{content:"\0025a0  "}ul.lst-kix_k1hefpyt8qdu-3{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-6{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-5{list-style-type:none}.lst-kix_4v4tuo10gdxg-3>li:before{content:"\0025cf  "}.lst-kix_4v4tuo10gdxg-1>li:before{content:"\0025cb  "}.lst-kix_cqitspa334da-8>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-4.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-4 0}ol.lst-kix_ixtk3xu5n7qn-1.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-1 0}ol.lst-kix_lx3h5q6cjds-2.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-2 0}.lst-kix_c6mggzy9bkhi-6>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-6}ol.lst-kix_c6mggzy9bkhi-0.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-0 0}ol.lst-kix_ixtk3xu5n7qn-7{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-6{list-style-type:none}.lst-kix_9dbpnvhyro1-0>li:before{content:"\0025cf  "}ol.lst-kix_ixtk3xu5n7qn-8{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-7.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-7 0}ul.lst-kix_9dbpnvhyro1-6{list-style-type:none}ul.lst-kix_9dbpnvhyro1-5{list-style-type:none}.lst-kix_9dbpnvhyro1-4>li:before{content:"\0025cb  "}ul.lst-kix_9dbpnvhyro1-4{list-style-type:none}ul.lst-kix_9dbpnvhyro1-3{list-style-type:none}ul.lst-kix_9dbpnvhyro1-2{list-style-type:none}.lst-kix_9dbpnvhyro1-5>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-6.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-6 0}ul.lst-kix_9dbpnvhyro1-1{list-style-type:none}ol.lst-kix_lx3h5q6cjds-8.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-8 0}ul.lst-kix_9dbpnvhyro1-0{list-style-type:none}ul.lst-kix_lx3h5q6cjds-0{list-style-type:none}ul.lst-kix_9dbpnvhyro1-8{list-style-type:none}ul.lst-kix_lx3h5q6cjds-1{list-style-type:none}ul.lst-kix_
9dbpnvhyro1-7{list-style-type:none}.lst-kix_9dbpnvhyro1-3>li:before{content:"\0025cf  "}ol.lst-kix_ixtk3xu5n7qn-1{list-style-type:none}.lst-kix_9dbpnvhyro1-2>li:before{content:"\0025a0  "}.lst-kix_c6mggzy9bkhi-4>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-4}ol.lst-kix_ixtk3xu5n7qn-0{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-3{list-style-type:none}.lst-kix_9dbpnvhyro1-1>li:before{content:"\0025cb  "}ol.lst-kix_ixtk3xu5n7qn-2{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-5{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-4{list-style-type:none}ul.lst-kix_qkescwycupop-8{list-style-type:none}.lst-kix_lx3h5q6cjds-7>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-7}ul.lst-kix_qkescwycupop-7{list-style-type:none}ul.lst-kix_qkescwycupop-6{list-style-type:none}ul.lst-kix_qkescwycupop-5{list-style-type:none}ul.lst-kix_qkescwycupop-4{list-style-type:none}ul.lst-kix_qkescwycupop-3{list-style-type:none}ul.lst-kix_qkescwycupop-2{list-style-type:none}ul.lst-kix_qkescwycupop-1{list-style-type:none}ul.lst-kix_qkescwycupop-0{list-style-type:none}ul.lst-kix_4vw5dpxrimee-6{list-style-type:none}ul.lst-kix_cqitspa334da-5{list-style-type:none}ul.lst-kix_4vw5dpxrimee-5{list-style-type:none}ul.lst-kix_cqitspa334da-6{list-style-type:none}ul.lst-kix_4vw5dpxrimee-4{list-style-type:none}ul.lst-kix_cqitspa334da-3{list-style-type:none}ul.lst-kix_4vw5dpxrimee-3{list-style-type:none}ul.lst-kix_cqitspa334da-4{list-style-type:none}ul.lst-kix_4vw5dpxrimee-2{list-style-type:none}.lst-kix_c6mggzy9bkhi-8>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-8}ol.lst-kix_lx3h5q6cjds-3.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-3 0}ul.lst-kix_4vw5dpxrimee-1{list-style-type:none}ul.lst-kix_4vw5dpxrimee-0{list-style-type:none}ul.lst-kix_cqitspa334da-7{list-style-type:none}ul.lst-kix_cqitspa334da-8{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-0.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-0 0}.lst-kix_c6mggzy9bkhi-2>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-2}ul.lst-kix_cqitspa334da-1{list-style-type:none}ul.lst-kix_cqitspa334da-2{list-style-type:none}ul.lst-kix_cqitspa334da-0{list-style-type:none}.lst-kix_ixtk3xu5n7qn-7>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-7}ol.lst-kix_ixtk3xu5n7qn-6.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-6 0}ul.lst-kix_4vw5dpxrimee-8{list-style-type:none}ul.lst-kix_4vw5dpxrimee-7{list-style-type:none}.lst-kix_cqitspa334da-7>li:before{content:"\0025cb  "}.lst-kix_jw98yuw3jje1-6>li:before{content:"\0025cf  "}.lst-kix_jw98yuw3jje1-8>li:before{content:"\0025a0  "}.lst-kix_cqitspa334da-3>li:before{content:"\0025cf  "}.lst-kix_cqitspa334da-5>li:before{content:"\0025a0  "}ol.lst-kix_ixtk3xu5n7qn-8.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-8 0}ol.lst-kix_c6mggzy9bkhi-5{list-style-type:none}.lst-kix_k1hefpyt8qdu-0>li:before{content:"\0025cf  "}ol.lst-kix_c6mggzy9bkhi-6{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-7{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-8{list-style-type:none}.lst-kix_k1hefpyt8qdu-4>li:before{content:"\0025cb  "}ol.lst-kix_c6mggzy9bkhi-0{list-style-type:none}.lst-kix_cqitspa334da-1>li:before{content:"\0025cb  "}.lst-kix_k1hefpyt8qdu-2>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-2{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-3{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-4{list-style-type:none}.lst-kix_k1hefpyt8qdu-8>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-5>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-5}.lst-kix_ixtk3xu5n7qn-1>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-1,lower-latin) ". "}.lst-kix_k1hefpyt8qdu-6>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-3>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-3,decimal) ". "}.lst-kix_lx3h5q6cjds-5>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-5}.lst-kix_lx3h5q6cjds-8>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-8,lower-roman) ". "}.lst-kix_ixtk3xu5n7qn-5>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-5,lower-roman) ". "}.lst-kix_qkescwycupop-6>li:before{content:"\0025cf  "}.lst-kix_qkescwycupop-8>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-7>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-7,lower-
latin) ". "}ul.lst-kix_4v4tuo10gdxg-0{list-style-type:none}.lst-kix_4vw5dpxrimee-6>li:before{content:"\0025cf  "}ul.lst-kix_4v4tuo10gdxg-1{list-style-type:none}.lst-kix_qkescwycupop-2>li:before{content:"\0025a0  "}.lst-kix_4vw5dpxrimee-4>li:before{content:"\0025cb  "}.lst-kix_4vw5dpxrimee-8>li:before{content:"\0025a0  "}.lst-kix_c6mggzy9bkhi-3>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-3,decimal) ". "}.lst-kix_c6mggzy9bkhi-7>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-7,lower-latin) ". "}ol.lst-kix_lx3h5q6cjds-7.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-7 0}ul.lst-kix_4v4tuo10gdxg-8{list-style-type:none}.lst-kix_4vw5dpxrimee-2>li:before{content:"\0025a0  "}ul.lst-kix_4v4tuo10gdxg-6{list-style-type:none}ul.lst-kix_4v4tuo10gdxg-7{list-style-type:none}ul.lst-kix_4v4tuo10gdxg-4{list-style-type:none}ul.lst-kix_4v4tuo10gdxg-5{list-style-type:none}.lst-kix_qkescwycupop-4>li:before{content:"\0025cb  "}ul.lst-kix_4v4tuo10gdxg-2{list-style-type:none}.lst-kix_c6mggzy9bkhi-1>li:before{content:"\0025cb  "}ul.lst-kix_4v4tuo10gdxg-3{list-style-type:none}.lst-kix_9dbpnvhyro1-7>li:before{content:"\0025cb  "}.lst-kix_lx3h5q6cjds-6>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-6}.lst-kix_lx3h5q6cjds-6>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-6,decimal) ". "}.lst-kix_4vw5dpxrimee-0>li:before{content:"\0025cf  "}.lst-kix_c6mggzy9bkhi-3>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-3}.lst-kix_ixtk3xu5n7qn-0>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-0}.lst-kix_lx3h5q6cjds-4>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-4,lower-latin) ". "}.lst-kix_qkescwycupop-0>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-6>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-6}.lst-kix_lx3h5q6cjds-0>li:before{content:"\0025cf  "}.lst-kix_lx3h5q6cjds-2>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-2,lower-roman) ". "}.lst-kix_4v4tuo10gdxg-8>li:before{content:"\0025a0  "}.lst-kix_4v4tuo10gdxg-6>li:before{content:"\0025cf  "}.lst-kix_4v4tuo10gdxg-2>li:before{content:"\0025a0  "}.lst-kix_4v4tuo10gdxg-4>li:before{content:"\0025cb  "}.lst-kix_4v4tuo10gdxg-0>li:before{content:"\0025cf  "}.lst-kix_c6mggzy9bkhi-5>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-5,lower-roman) ". "}ol.lst-kix_lx3h5q6cjds-6.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-6 0}ol{margin:0;padding:0}table td,table th{padding:0}.c0{margin-left:36pt;orphans:2;widows:2;padding-left:0pt}.c21{padding-top:0pt;padding-bottom:0pt;line-height:1.15;text-align:left}
    .c22{background-color:#ffffff;max-width:511.2pt;padding:36pt 50.4pt 36pt 50.4pt}.c5{background-color:#ffffff;font-size:9pt;color:#333333}.c1{vertical-align:sub;font-family:"Times New Roman";font-style:italic}.c14{margin-left:72pt;padding-left:0pt}.c16{background-color:#ffffff;color:#121212}.c4{orphans:2;widows:2}.c17{padding:0;margin:0}.c7{color:inherit;text-decoration:inherit}.c2{color:#1155cc;text-decoration:underline}.c18{padding-top:14pt;padding-bottom:4pt}.c20{color:#000000}.c19{font-size:10pt}.c12{font-weight:bold}.c13{font-size:12pt}.c23{text-align:center}.c3{font-style:italic}.c8{page-break-after:avoid}.c24{text-decoration:underline}.c10{font-family:"Times New Roman"}.c11{height:11pt}.c9{font-size:9pt}.c6{vertical-align:sub}.c15{vertical-align:super}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}

    h1{padding-top:14pt;color:#000000;text-decoration:underline;font-size:18pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}
    h2{padding-top:12pt;color:#000000;font-weight:bold;font-size:14pt;padding-bottom:0pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}
    h3{padding-top:6pt;color:#434343;font-weight:bold;font-size:13pt;padding-bottom:0pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}
    h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}
    h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}
    h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}
    h1Top{padding-top:0pt;color:#000000;text-decoration:underline;font-size:18pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}

</style> <title>twocolumns</title>
  </head>
  <body>
    <div  id="includeNav"> </div>
    <div class="c22">
    <div  id="container">
      <div  style="width: 199px;"  id="navbar"><span  style="font-weight: bold;"><span
             style="font-family: Arial;"><span
               class="c12"><a
                 href="#content">Introduction</a><br>
            </span><span>&nbsp;</span><br>
            <a  href="#h.59lv7l35vmfq"><span  class="c12">About traditional
                metrics</span></a><br>
            <span>&nbsp;<br>
              <a  href="#h.xnwbiv8sjyzq">A</a></span><span  class="c12"><a  href="#h.xnwbiv8sjyzq">bout
                GR metrics</a><br>
              <br>
            </span><span  class="c12"><a  href="#h.jxm7uvdes7b1">Exploration
                tool</a><br>
              <br>
            </span><a  href="#h.nmbmnok8t8li"><span  class="c12">Online GR
                calculator</span></a></span></span>
        <ol  class="c17 lst-kix_c6mggzy9bkhi-0"  start="2">
        </ol>
        <span  style="font-weight: bold;"><span  style="font-family: Arial;"> </span></span>
        <ul  class="c17 lst-kix_c6mggzy9bkhi-1 start">
        </ul>
        <span  style="font-weight: bold;"><span  style="font-family: Arial;"> </span></span>
        <p  class="c4 c11"><span></span></p>
        <h1  class="c4 c8"  id="h.lvf007a1bk8u"> </h1>
      </div>
      <div  style="width: 849px; margin-left: 224.633px;"  id="content">
        <div> <h1top> <span  style="font-weight: bold; font-family: Arial;">Introduction</span>
          </h1top> </div>
        <p  class="c4 c11"><span></span></p>
        <p  style="width: 871px; margin-left: -2px;"  class="c4"><span>Drug
            sensitivity and resistance are quantified using </span><span  class="c3">IC</span><span
             class="c3 c6">50</span><span>&nbsp;or
            </span><span  class="c3">E</span><span  class="c3 c6">max</span><span>&nbsp;</span><span>values</span><span>,
            but these metrics suffer from a fundamental flaw when applied to
            growing cells: they are highly sensitive to the number of divisions
            that take place over the course of a response assay (see the
            exploration tool below). Division rate varies across cell lines and
            experimental conditions. The dependency of </span><span  class="c3">IC</span><span
             class="c3 c6">50</span><span>&nbsp;and
            </span><span  class="c3">E</span><span  class="c3 c6">max</span><span>&nbsp;on
            division rate creates artefactual correlations between genotype and
            drug sensitivity while obscuring important biological insights and
            interfering with biomarker discovery. To address this, we derived
            alternative drug response metrics that are insensitive to division
            number. These metrics are based on </span><span>estimating growth
            rate inhibition (GR)</span><span>&nbsp;in the presence of a drug
            (relative to an untreated control) using endpoint or time-course
            assays. The latter provides a direct measure of phenomena such as
            adaptive drug resistance. Theory and experiments published in </span><span>Hafner
            et al. </span><span>(2016)</span><span>&nbsp;show that </span><span
             class="c3">GR</span><span
             class="c3 c6">50</span><span>&nbsp;and
            </span><span  class="c3">GR</span><span  class="c3 c6">max</span><span
             class="c3">&nbsp;</span><span>are
            superior to </span><span  class="c3">IC</span><span  class="c3 c6">50</span><span>&nbsp;and
            </span><span  class="c3">E</span><span  class="c3 c6">max</span><span>&nbsp;for
            assessing the effects of drugs on dividing cells. Moreover, adopting
            GR metrics requires only modest changes in experimental protocols.
            GR metrics should improve the use of drugs to identify response
            biomarkers, study mechanisms of cell signaling and growth and
            identify drugs effective on specific patient-derived tumor cells.
            Through this website we provide an </span><span>online tool</span><span>&nbsp;to
            calculate </span><span>GR metrics from user-provided data. </span><span>Scripts
            are also available on </span><span>GitHub</span><span>.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4 c23"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 661.30px; height: 260.70px;"><img
               alt="Screen Shot 2016-03-25 at 2.43.16 PM.png"
               src="images/image03.png"
               style="width: 661.30px; height: 260.70px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span  class="c9 c12">Exploration Tool.</span><span  class="c9">&nbsp;This
            interactive model of drug response illustrates the dependency of
            relative cell count and </span><span  class="c3 c9">IC</span><span
             class="c3 c9 c6">50</span><span
             class="c3 c9">/E</span><span
             class="c3 c9 c6">max</span><span
             class="c9">&nbsp;metrics
            on cell division time. Adjust the sliders to alter the model
            parameters, or select one of buttons to display the output of the
            model for a defined drug response profile (cytostatic, partial
            cytostatic, or cytotoxic). (left) Normalized cell count over time at
            different concentrations of drug; (middle) the resulting IC curve
            and IC metrics; (right) the resulting GR curve and GR metrics.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>On this website you will find:</span></p>
        <ul  class="c17 lst-kix_4v4tuo10gdxg-0 start">
          <li  class="c0"><span>a discussion of </span><span>traditional
              metrics based on relative cell count</span><span>&nbsp;</span></li>
          <li  class="c0"><span>a discussion of the new metrics based on </span><span>normalized
              growth rate inhibition (GR)</span><span>&nbsp;</span></li>
          <li  class="c0"><span>instructions for calculating GR metrics using
              our </span><span>online calculator</span></li>
          <li  class="c0"><span>interactive tools for browsing </span><span>LINCS
              dose-response datasets</span><span>&nbsp;that were evaluated using
              GR metrics</span></li>
        </ul>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>Additional information about calculating GR metrics
            can be found in the tutorial on the</span><span><a  class="c7"  href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools/blob/master/GR_tools_tutorial.pdf&amp;sa=D&amp;ust=1460076611314000&amp;usg=AFQjCNH7y-NnNXkkVmoLzsZWw_VwDFZhnA">&nbsp;</a></span><span
             class="c2"><a
               class="c7"
               href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools/blob/master/GR_tools_tutorial.pdf&amp;sa=D&amp;ust=1460076611315000&amp;usg=AFQjCNH4JInJkecyzbUj9Wkz7u8ofgvLhw">Sorger
              lab GR50 Tools Git repository</a></span><span>. Applications of GR
            metrics are further discussed in </span><span>Hafner et al. (2016)</span><span>.
          </span><span>Please cite this paper for all applications of GR metrics
            and/or this online calculator.</span></p>
        <p  class="c4"><span>&nbsp;</span></p>
        <h3  class="c4 c8"  id="h.ju4t6rbvcpw1"><span>Funding Sources</span></h3>
        <p  class="c4"><span>The GR metrics model and the associated
            computational scripts were developed by members of the Sorger lab at
            the Harvard Medical School (HMS) LINCS Center, </span><span  class="c16">which
            is funded by NIH grant U54 HL127365. </span><span>The online GR
            tools were developed by LINCS-BD2K </span><span  class="c16"></span><span
             class="c16">Data
            Coordination and Integration center, which is funded by NIH grant
            U54HL127624,</span><span> </span><span  class="c16">in
            collaboration with the HMS LINCS Center.</span></p>
        <h3  class="c4 c8"  id="h.cz4qiafkw425"><span>References</span></h3>
        <p  class="c4"><span>1. Hafner, M., Niepel, M., Chung, M., and Sorger,
            P.K. (in press) Metrics of drug sensitivity and resistance based on
            growth rate inhibition correct for the confounding effects of
            variable division rates. </span><span  class="c3">Nat Methods</span><span>.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>-----</span></p>
        <p  class="c4 c11"><span></span></p>
        <h1  class="c4 c8"  id="h.59lv7l35vmfq"><span>About traditional metrics</span></h1>
        <p  class="c4"><span>Commonly, relative cell count at the end of
            treatment is used to assess drug response. Across a range of
            concentrations, the measured cell coun</span><span>t</span><span>&nbsp;or
            a surrogate of it (e.g. measurement of ATP using CellTiter-GloÂ®) is
            normalized to the cell count of DMSO-treated controls grown on the
            same plate under the same conditions. For each condition
            (combination of cell line, drug, and drug concentration), we define
            the relative cell count as </span><span  class="c3 c10">x(c)/x</span><span
             class="c1">ctrl</span><span>,
            where </span><span  class="c3 c10">x(c)</span><span>&nbsp;is the
            count in the presence of drug and </span><span  class="c3 c10">x</span><span
             class="c1">ctrl</span><span>&nbsp;is
            the 50%-trimmed mean of the count for control cells. Based on a
            sigmoidal curve fitted to the relative cell count across different
            concentrations, one can define:</span></p>
        <p  class="c4 c11"><span></span></p>
        <ul  class="c17 lst-kix_qnsw2cr2b80j-0 start">
          <li  class="c0"><span  class="c3">IC</span><span  class="c3 c6">50</span><span>&nbsp;(50%
              relative cell count), which is the most commonly used metric but
              one that can only be defined if the relative cell count decreases
              during the assay to </span><span>below</span><span>&nbsp;50% of
              the starting value;</span></li>
          <li  class="c0"><span  class="c3">EC</span><span  class="c3 c6">50</span><span>&nbsp;(half-point
              of the sigmoidal curve);</span></li>
          <li  class="c0"><span  class="c3">E</span><span  class="c3 c6">inf</span><span>&nbsp;(the
              asymptotic efficacy), which differs from </span><span  class="c3">E</span><span
               class="c3 c6">max</span><span>&nbsp;(the
              maximal measured efficacy); and</span></li>
          <li  class="c0"><span  class="c3">AUC </span><span>(area under, or
              over, the curve), which captures both </span><span  class="c3">IC</span><span
               class="c3 c6">50</span><span>&nbsp;and
              </span><span  class="c3">E</span><span  class="c3 c6">max</span><span>&nbsp;to
              some extent and is more robust to experimental noise than other
              metrics.</span></li>
        </ul>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>More details on dose-response assays and
            traditional metrics can be found in</span><span>&nbsp;Sebaugh et al.
            (2010).</span><span>&nbsp;</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4 c23"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 536.99px; height: 249.50px;"><img
               alt=""
               src="images/image07.png"
               style="width: 536.99px; height: 249.50px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span  class="c12 c9">Examples of dose-response curves
            based on relative cell count.</span><span  class="c9">&nbsp;In the
            first example (left), a strong drug response results in an </span><span
             class="c3 c9">E</span><span
             class="c3 c9 c6">inf</span><span
             class="c3 c9">&nbsp;</span><span
             class="c9">close
            to 0 and a well-defined </span><span  class="c3 c9">IC</span><span
             class="c3 c9 c6">50</span><span
             class="c9">.
            In the second (right), a partial response results in an </span><span
             class="c3 c9">E</span><span
             class="c3 c9 c6">inf</span><span
             class="c9">&nbsp;above
            0.5 and an undefined </span><span  class="c3 c9">IC</span><span  class="c3 c9 c6">50</span><span
             class="c9">.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>-----</span></p>
        <p  class="c4 c11"><span></span></p>
        <h1  class="c4 c8"  id="h.xnwbiv8sjyzq"><span>About GR metrics</span></h1>
        <p  class="c4"><span>As an alternative to traditional metrics, we
            propose to use GR metrics, which are based on inhibition of the
            growth rate over the course of the assay and are independent of the
            division rate of the assayed cell lines.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>Growth can be estimated at different concentrations
            based on the cell count at the time of treatment (</span><span  class="c3">x</span><span
             class="c3 c6">0</span><span>),
            the cell count in the untreated control (</span><span  class="c3">x</span><span
             class="c3 c6">ctrl</span><span>),
            and the cell count after treatment at concentration </span><span  class="c3">c</span><span>&nbsp;(</span><span
             class="c3">x(c)</span><span>):
            </span></p>
        <p  class="c4"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 415.00px; height: 98.00px;"><img
               alt=""
               src="images/image04.png"
               style="width: 415.00px; height: 98.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span>This equation assumes exponential growth and
            constant growth inhibition by the drug. Many phenomena such as drug
            efflux, homeostasis and adaptation can result in non-exponential
            growth. In such cases, time course assays and time-dependent GR
            values are better suited to evaluating drug response. Given
            measurements of cell count at different time points, time-dependent
            GR values are defined as:</span></p>
        <p  class="c4"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 653.00px; height: 111.00px;"><img
               alt=""
               src="images/image10.png"
               style="width: 653.00px; height: 111.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 218.67px;"><img
               alt=""
               src="images/image02.png"
               style="width: 681.60px; height: 218.67px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span  class="c5 c12">Different methods can be used to
            evaluate GR values: </span><span  class="c5">(left) Conceptual
            approach based on growth rates (</span><span  class="c5 c3 c10">k</span><span
             class="c5 c1">0</span><span
             class="c5">&nbsp;and</span><span
             class="c5 c3 c10">&nbsp;k(c)</span><span
             class="c5">);
            (middle) fixed-interval approach based on cell number at the start
            (x0) and end of the experiment (</span><span  class="c5 c3 c10">x</span><span
             class="c5 c1">ctrl</span><span
             class="c5">&nbsp;and
            </span><span  class="c5 c3 c10">x(c)</span><span  class="c5">); and
            (right) time-dependent approach based on cell count before and after
            a time interval </span><span  class="c5 c3 c10">2 Ã— ??t (x(c, t Â±
            ??t))</span><span  class="c5">.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span  class="c3">GR(c) </span><span>values (or
            time-dependent </span><span  class="c3">GR(c,t)</span><span>&nbsp;values
            at a given time </span><span  class="c3">t</span><span>)</span><span>&nbsp;across
            a range of concentrations are fitted to a sigmoidal curve:</span></p>
        <p  class="c4"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 634.30px; height: 97.66px;"><img
               alt=""
               src="images/image05.png"
               style="width: 634.30px; height: 97.66px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span>where the fitted parameters are:</span></p>
        <ul  class="c17 lst-kix_cqitspa334da-0 start">
          <li  class="c0"><span  class="c12 c3">GR</span><span  class="c12 c3 c6">inf</span><span>:
              the effect of the drug at infinite concentration (</span><span  class="c3">GR</span><span
               class="c3 c6">inf</span><span
               class="c3">&nbsp;=
              GR(c??)</span><span>). </span><span  class="c3">GR</span><span  class="c3 c6">inf</span><span>&nbsp;lies
              between -1 and 1. Negative values correspond to cytotoxic
              responses (i.e., induction of cell death), and a value of 0
              corresponds to a fully cytostatic response.</span></li>
          <li  class="c0"><span  class="c12 c3">h</span><span  class="c12 c3 c6">GR</span><span>:
              the Hill coefficient of the fitted curve, which reflects how steep
              the dose-response curve is. In practice, we typically constrain </span><span
               class="c3">h</span><span
               class="c3 c6">GR</span><span>&nbsp;to
              a value between 0.1 and 5.</span></li>
          <li  class="c0"><span  class="c12 c3">GEC</span><span  class="c12 c3 c6">50</span><span>:
              the concentration at half-maximal effect. To avoid artefacts in
              curve fitting we constrain </span><span  class="c3">GEC</span><span
               class="c3 c6">50</span><span>&nbsp;to
              be within two orders of magnitude higher and lower than the
              experimentally tested concentration range. (In practice, this is
              usually about 10</span><span  class="c15">-7</span><span>&nbsp;to
              10</span><span  class="c15">3</span><span>&nbsp;?M.)</span></li>
        </ul>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>If the fit of the curve is not significantly better
            than that of a flat curve (i.e., </span><span  class="c3">GR(c) ?
            GR</span><span  class="c3 c6">inf</span><span>) based on an F-test
            with cutoff of p = 0.05, the response is considered flat, and the
            parameter </span><span  class="c3">GEC</span><span  class="c3 c6">50</span><span>&nbsp;is
            set to 0.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>If time-dependent </span><span  class="c3">GR(c,t)</span><span>&nbsp;values
            are used, GR metrics can be estimated at a different time points to
            study how sensitivity evolves over time.</span></p>
        <h3  class="c4 c18"  id="h.e6m8nf1dasrb"><span  class="c20">Inferred
            drug response metrics</span></h3>
        <p  class="c4"><span>The </span><span  class="c3">GR</span><span  class="c3 c6">50</span><span>&nbsp;value
            is the concentration of drug at which </span><span  class="c3">GR</span><span>(</span><span
             class="c3">c
            = GR</span><span  class="c3 c6">50</span><span>)</span><span  class="c3">&nbsp;=
            0.5</span><span>. If the value for </span><span  class="c3">GR</span><span
             class="c3 c6">inf</span><span>&nbsp;is
            above 0.5, the </span><span  class="c3">GR</span><span  class="c3 c6">50</span><span>&nbsp;value
            is not defined and is therefore set to </span><span  class="c3">+?</span><span>.
            By extension, other thresholds can be defined in a similar manner.
            For example, </span><span  class="c3">GR</span><span  class="c3 c6">100</span><span>&nbsp;corresponds
            to the concentration at which a drug is fully cytostatic: </span><span
             class="c3">GR</span><span>(</span><span
             class="c3">c
            = GR</span><span  class="c3 c6">100</span><span>)</span><span  class="c3">&nbsp;=
            0</span><span>.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span  class="c3">GR</span><span  class="c3 c6">max </span><span>is
            the maximum effect of the drug at the highest tested concentration.
            It lies between -1 and 1. A value of 0 corresponds to a fully
            cytostatic response, and negative values correspond to a cytotoxic
            response. </span><span  class="c3">GR</span><span  class="c3 c6">max</span><span>&nbsp;can
            be estimated from the fitted curve or obtained directly from
            experimental data. (We often do the later.)</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>For time course data, all metrics are evaluated at
            each time point individually.</span></p>
        <h3  class="c4 c18"  id="h.1pf15leifx2n"><span  class="c20">Area under
            the curve and over the curve (GR</span><span  class="c6 c20">AOC</span><span
             class="c20">)</span></h3>
        <p  class="c4"><span>Another common metric for quantifying dose response
            is the area under the response curve (AUC), which is based on
            integrating the dose-response curve over the range of tested
            concentrations. In the case of </span><span  class="c3">GR</span><span>&nbsp;curves,
            which can have negative values, it is more intuitive to use the area
            over the curve:</span></p>
        <p  class="c4"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 61.33px;"><img
               alt=""
               src="images/image08.png"
               style="width: 681.60px; height: 61.33px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span>where </span><span  class="c3">GR</span><span>(</span><span
             class="c3">c</span><span
             class="c3 c6">i</span><span>)
            are measured GR values at discrete concentrations </span><span  class="c3">c</span><span
             class="c3 c6">i</span><span>.
          </span><span  class="c3">GR</span><span  class="c3 c6">AOC</span><span
             class="c3">&nbsp;</span><span>has
            the benefit that, in the case of no response, it has a value of 0.
            It is important to note that </span><span  class="c3">GR</span><span
             class="c3 c6">AOC</span><span>&nbsp;values
            (like conventional AUC) can only be used to compare responses
            evaluated across the same drug concentration range.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>The </span><span  class="c3">GR</span><span  class="c3 c6">AOC</span><span>&nbsp;value
            captures variation in potency and efficacy at the same time. The
            calculation of </span><span  class="c3">GR</span><span  class="c3 c6">AOC</span><span>&nbsp;at
            discrete (experimentally determined) concentrations has the
            advantage that it does not require curve fitting and is therefore
            free of fitting artifacts. This is especially useful for assays
            where fewer than five concentrations are measured and curve fitting
            is unreliable. </span><span  class="c3">GR</span><span  class="c3 c6">AOC</span><span>&nbsp;values
            are also more robust to experimental noise than metrics derived from
            curve fitting; e.g. </span><span  class="c3">GR</span><span  class="c3 c6">max</span><span>&nbsp;is
            particularly sensitive to outlier values when directly obtained from
            data.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 642.00px; height: 612.00px;"><img
               alt=""
               src="images/image01.png"
               style="width: 642.00px; height: 612.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span  class="c5 c12">Examples of dose-response curves
            and fits.</span><span  class="c5">&nbsp;The upper panels depict
            strong responses to drugs for which all sensitivity parameters can
            be defined. In contrast, in the case shown in the lower left panel,
          </span><span  class="c5 c3">GR</span><span  class="c5 c3 c6">inf</span><span
             class="c5">&nbsp;is
            above 0.5, so </span><span  class="c5 c3">GR</span><span  class="c5 c3 c6">50</span><span
             class="c5">&nbsp;cannot
            be defined (and thus is set to ?). In the case shown in the lower
            right panel, the response is weak and noisy, so the sigmoidal fit is
            not significant, and a straight flat line is fitted. Nevertheless,
            only </span><span  class="c5 c3">GR</span><span  class="c5 c3 c6">AUC</span><span
             class="c5">&nbsp;and
            </span><span  class="c5 c3">GR</span><span  class="c5 c3 c6">inf</span><span
             class="c5">&nbsp;can
            be defined.</span></p>
        <p  class="c4"><span  class="c19">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p>
        <h1  class="c4 c8"  id="h.jxm7uvdes7b1"><span>Exploration Tool</span></h1>
        <p  class="c4"><span>We used computer simulation (see below) to model
            drug response by three idealized cell lines having identical
            sensitivity to a partial, or complete </span><span>cytostatic</span><span>&nbsp;drug
            (i.e., a drug that arrests but does not kill cells), or a cytotoxic
            drug (i.e., a drug that kills cells) and different division times (</span><span
             class="c3">T</span><span
             class="c3 c6">d</span><span>).
            For example, the lower quartile, median, and upper quartile of the
            division times for breast cancer cell lines has been reported as
            1.8, 2.4, or 3.9 days, respectively (</span><span>Heiser et al.
            (2012)</span><span>). These values are similar to those of NCI-60
            cells. In a slow-dividing cell line (</span><span  class="c3">T</span><span
             class="c3 c6">d</span><span>&nbsp;&gt;
            3.9 d), the total number of cells does not double in a typical
            three-day assay; thus </span><span  class="c3">E</span><span  class="c3 c6">max</span><span>&nbsp;?
            0.5 and </span><span  class="c3">IC</span><span  class="c3 c6">50</span><span>&nbsp;are
            undefined. In the case of the two faster-growing cell lines, </span><span
             class="c3">IC</span><span
             class="c3 c6">50</span><span>&nbsp;and
            </span><span  class="c3">E</span><span  class="c3 c6">max</span><span>&nbsp;
            values fall as division rate increases simply because cell number
            (or CTG value) is normalized to a drug</span><span><span>-naïve</span>
            control in which cell number increases as division time falls. </span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4 c23"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 661.30px; height: 260.70px;"><img
               alt="Screen Shot 2016-03-25 at 2.43.16 PM.png"
               src="images/image03.png"
               style="width: 661.30px; height: 260.70px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span  class="c12 c9">Exploration Tool.</span><span  class="c9">&nbsp;This
            interactive model of drug response illustrates the dependency of
            relative cell count and </span><span  class="c3 c9">IC</span><span
             class="c3 c9 c6">50</span><span
             class="c3 c9">/E</span><span
             class="c3 c9 c6">ma</span><span
             class="c9 c6">x</span><span
             class="c9">&nbsp;metrics
            on cell division time. Adjust the sliders to alter the model
            parameters, or select one of buttons to display the output of the
            model for a defined drug response profile (cytostatic, partial
            cytostatic, or cytotoxic). (left) Normalized cell count over time at
            different concentrations of drug; (middle) the resulting IC curve
            and IC metrics; (right) the resulting GR curve and GR metrics.</span></p>
        <p  class="c4 c11"><span  class="c9"></span></p>
        <p  class="c4 c11"><span  class="c9"></span></p>
        <p  class="c4"><span>To simulate the effect of division time on </span><span
             class="c3">GR</span><span>&nbsp;and
            conventional drug-response metrics under different assumptions about
            the degree of cytostasis or cell killing, we developed a theoretical
            model of drug response. To the first approximation, cell growth can
            be considered exponential, with drugs either decreasing the division
            rate or killing cells in a cell cycle-dependent manner:</span></p>
        <p  class="c4"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
            &nbsp; &nbsp; &nbsp;
            &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 142.67px;"><img
               alt=""
               src="images/image06.png"
               style="width: 681.6px; height: 142.67px; margin-left: 0px; margin-top: 0px; transform: rotate(0rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span>where </span><span  class="c3">x</span><span>&nbsp;is
            the cell count, </span><span  class="c3">k</span><span>&nbsp;is the
            untreated growth rate (per day), </span><span  class="c3">c</span><span>&nbsp;is
            the drug concentration, </span><span  class="c3">S</span><span  class="c3 c6">M</span><span>&nbsp;is
            the maximal inhibitory effect,</span><span  class="c3">&nbsp;SC</span><span
             class="c3 c6">50</span><span>&nbsp;is
            the concentration at half-maximal effect of drug, and</span><span  class="c3">&nbsp;h</span><span>&nbsp;is
            the Hill coefficient. The growth rate </span><span  class="c3 c10">k</span><span>&nbsp;corresponds
            to the division rate </span><span  class="c3 c10">k</span><span  class="c1">0</span><span>&nbsp;as
            </span><span  class="c3 c10">k </span><span  class="c10">= ln(2)?</span><span
             class="c3 c10">k</span><span
             class="c1">0</span><span
             class="c10">&nbsp;=
            ln(2)/</span><span  class="c3 c10">T</span><span  class="c1">d</span><span>,
            where </span><span  class="c3 c10">T</span><span  class="c1">d</span><span>&nbsp;is
            the division time. </span><span  class="c3">S</span><span  class="c3 c6">M</span><span>&nbsp;can
            be larger than 1 to account for drugs inducing cell death at a
            specific phase of the cell cycle. </span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>Integrating these equations for an assay of </span><span
             class="c3">t</span><span>&nbsp;days
            yields the cell count at concentration </span><span  class="c3">c</span><span>:</span></p>
        <p  class="c4"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
            &nbsp; &nbsp; &nbsp;
            &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 118.67px;"><img
               alt=""
               src="images/image11.png"
               style="width: 681.60px; height: 118.67px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span>where </span><span  class="c3 c10">x</span><span  class="c1">0</span><span
             class="c10">&nbsp;=
            </span><span  class="c3 c10">x</span><span  class="c10">(</span><span
             class="c3 c10">t</span><span
             class="c10">&nbsp;=
            </span><span  class="c3 c10">0</span><span  class="c10">)</span><span>&nbsp;is
            the cell number at the time of treatment. Thus, the relative cell
            count is:</span></p>
        <p  class="c4"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
            &nbsp; &nbsp; &nbsp;
            &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span  class="c10">&nbsp;</span><span>&nbsp;
            </span><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 80.00px;"><img
               alt=""
               src="images/image00.png"
               style="width: 681.60px; height: 80.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span><span>&nbsp;where
            </span><span  class="c3">x</span><span  class="c3 c6">ctrl</span><span>&nbsp;</span><span
             class="c3">?
            x(0)</span><span>, and the normalized growth rate inhibition (</span><span
             class="c3">GR</span><span>&nbsp;value)
            is:</span></p>
        <p  class="c4"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
            &nbsp; &nbsp; &nbsp;
            &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 85.33px;"><img
               alt=""
               src="images/image09.png"
               style="width: 681.60px; height: 85.33px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"
               title=""></span></p>
        <p  class="c4"><span  class="c13">This equation for </span><span  class="c13 c3">GR(c)</span><span
             class="c13">&nbsp;is
            independent of the length of the assay </span><span  class="c3 c10 c13">t</span><span
             class="c13">&nbsp;and
            the untreated growth rate </span><span  class="c13 c3">k</span><span
             class="c13">,</span><span
             class="c13 c3">&nbsp;</span><span
             class="c13">and,
            thus, the metrics </span><span  class="c13 c3">GR</span><span  class="c13 c3 c6">50</span><span
             class="c13">,
          </span><span  class="c13 c3">GR</span><span  class="c13 c3 c6">max</span><span
             class="c13">,
          </span><span  class="c13 c3">GR</span><span  class="c13 c3 c6">AOC</span><span
             class="c13">,
            and </span><span  class="c13 c3">h</span><span  class="c13 c3 c6">GR</span><span
             class="c13">&nbsp;are
            also independent of </span><span  class="c13 c3 c10">t</span><span
             class="c13">&nbsp;and
            </span><span  class="c13 c3 c10">k</span><span  class="c13">. </span></p>
        <p  class="c4 c11"><span  class="c9"></span></p>
        <p  class="c4 c11"><span  class="c9"></span></p>
        <p  class="c4"><span>-----</span></p>
        <p  class="c4 c11"><span></span></p>
        <h1  class="c4 c8"  id="h.nmbmnok8t8li"><span>Online GR Calculator</span></h1>
        <h2  class="c4 c8"  id="h.jtb73mccvg4m"><span>About the GR calculator</span></h2>
        <p  class="c4"><span>Through the accompanying webpages we provide online
            tools that allow users to upload their own endpoint data, calculate
            the corresponding GR values and GR metrics, and compare their
            results across the variables in the assay, such as cell line, agent
            (drug), time and replicate. Matlab and Python scripts for
            calculating GR value and GR metrics also are available through the</span><span><a
               class="c7"
               href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools&amp;sa=D&amp;ust=1460076611371000&amp;usg=AFQjCNEWelSK5trMTpTdD2AVGUr2P4Fb1g">&nbsp;</a></span><span
             class="c2"><a
               class="c7"
               href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools&amp;sa=D&amp;ust=1460076611371000&amp;usg=AFQjCNEWelSK5trMTpTdD2AVGUr2P4Fb1g">Sorger
              lab GR50 Tools Git repository</a></span><span>.</span></p>
        <h2  class="c4 c8"  id="h.7uaaomtim0py"><span>Input data:</span></h2>
        <p  class="c4"><span>The input .tsv file(s) must have the following
            column headers (first row of the file):</span></p>
        <ul  class="c17 lst-kix_4vw5dpxrimee-0 start">
          <li  class="c0"><span  class="c12">concentration</span><span>&nbsp;=
              concentration of the perturbagen on which dose-response curves
              will be evaluated</span></li>
        </ul>
        <ul  class="c17 lst-kix_9dbpnvhyro1-0 start">
          <li  class="c0"><span  class="c12">cell count</span><span>&nbsp;in a
              column labeled </span><span  class="c3">cell_count </span><span>=</span><span>&nbsp;the
              measure of cell number (or a surrogate of cell number such as
              CellTiter-GloÂ® staining) after treatment</span></li>
          <li  class="c0"><span  class="c12">control cell count</span><span>&nbsp;in
              a column labeled </span><span  class="c3">cell_count__ctrl</span><span>&nbsp;
              = the measure of cell number in control (e.g. DMSO-treated) wells
              from the same plate</span></li>
          <li  class="c0"><span  class="c12">time 0 cell count</span><span>&nbsp;in
              a column labeled </span><span  class="c3">cell_count__time0 </span><span>=
              the measure of cell number in untreated wells grown in parallel
              until the time of treatment</span></li>
        </ul>
        <p  class="c4"><span>&nbsp;</span></p>
        <p  class="c4"><span>All other columns will be treated as additional key
            variables (e.g. </span><span  class="c3">cell_line</span><span>, </span><span
             class="c3">drug</span><span>,
          </span><span  class="c3">time</span><span>, </span><span  class="c3">replicate</span><span>).</span></p>
        <p  class="c4 c11"><span></span></p>
        <h2  class="c4 c8"  id="h.57wjmingbrln"><span>Calculated metrics: </span></h2>
        <p  class="c4"><span>The following GR metrics are calculated: </span></p>
        <ul  class="c17 lst-kix_jw98yuw3jje1-0 start">
          <li  class="c0"><span  class="c3">GR</span><span  class="c3 c6">50</span><span>,
              the concentration at which the effect reaches a GR value of 0.5
              based on interpolation of the fitted curve.</span></li>
          <li  class="c0"><span  class="c3">GR</span><span  class="c3 c6">inf</span><span
               class="c3">&nbsp;</span><span>=
            </span><span  class="c3">GR</span><span  class="c3">(c ? inf)</span><span>,
              which reflects asymptotic drug efficacy.</span></li>
          <li  class="c0"><span  class="c3">GR</span><span  class="c3 c6">max</span><span>,
              the effect at the highest tested concentration. Note that </span><span
               class="c3">GR</span><span
               class="c3 c6">max</span><span>&nbsp;can
              differ from </span><span  class="c3">GR</span><span  class="c3 c6">inf</span><span>&nbsp;if
              the dose response does not reach its plateau value.</span></li>
          <li  class="c0"><span  class="c3">GEC</span><span  class="c3 c6">50</span><span>,
              the drug concentration at half-maximal effect, which reflects the
              potency of the drug.</span></li>
          <li  class="c0"><span  class="c3">h</span><span  class="c3 c6">GR</span><span>,
              Hill coefficient of the sigmoidal curve, which reflects how steep
              the dose-response curve is.</span></li>
          <li  class="c0"><span  class="c3">GR</span><span  class="c3 c6">AOC</span><span>,
              the area over the dose-response curve, which is the integral of </span><span
               class="c3">1-GR(c)</span><span>&nbsp;over
              the range of concentrations tested.</span></li>
        </ul>
        <p  class="c4"><span>&nbsp;</span></p>
        <p  class="c4"><span>In addition, the online calculator reports the
            r-squared of the fit and evaluates the significance of the sigmoidal
            fit based on an F-test. Further information about these calculations
            is available through our </span><span>GR tutorial<!--
    span--><span>.</span></span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>The results of analysis of existing LINCS
            dose-response datasets using the GR model are available in the </span><span
             class="c3">LINCS
            GR Data Browser</span><span>&nbsp;tab.</span></p>
        <h2  class="c4 c8"  id="h.awowafiaa46j"><span>Analysis and visualization
            tools:</span></h2>
        <p  class="c4"><span>The following tabs allow users to analyze and
            visualize their data and the calculated GR metrics.</span></p>
        <p  class="c4 c11"><span  class="c12"></span></p>
        <ul  class="c17 lst-kix_qkescwycupop-0 start">
          <li  class="c0"><span  class="c12">Data Tables </span><span>displays
              the</span><span>&nbsp;uploaded data and calculated GR values as
              well as the inferred GR metrics. Data can be downloaded in .csv or
              .tsv format.</span></li>
          <li  class="c0"><span  class="c12">Dose Response by Condition </span><span>plots
              the d</span><span>ata points and fitted dose-response curves for
              each condition. If no specific conditions are selected, all data
              will be overlaid on a single plot. To display a subset of the
              data, select specific conditions to display (e.g. a specific cell
              line or drug). Mousing over the plot displays the </span><span>GR
              values</span><span>&nbsp;and the corresponding concentration.
              Plots can be downloaded in a variety of image formats.</span></li>
          <li  class="c0"><span  class="c12">Dose Response Grid </span><span>shows
              the fitted </span><span>dose-response curves side by side and
              grouped according to the selected variables. 'Selector variable'
              and </span><span>'grid variable' define which plots are displayed</span><span>.
              'Selector variable' also defines the variable displayed in the
              selector box to the left of the plots.</span></li>
          <li  class="c0"><span  class="c12">GR Metric Comparison </span><span>shows
              a s</span><span>catter plot of the a given GR metric across
              different conditions. Users can select which metric to plot
              relative to which experimental variable. Mousing over the plot
              displays the plotted GR metrics. Plots can be downloaded in a
              variety of image formats.</span></li>
        </ul>
        <h2  class="c4 c8"  id="h.t551oewdm9gl"><span>Feedback</span></h2>
        <p  class="c4"><span>We welcome </span><span>your feedback</span><span>&nbsp;on
            all of these tools and resources.</span></p>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4"><span>&nbsp;</span></p>
        <p  class="c4"><span>-----</span></p>
        <p  class="c4 c11"><span></span></p>
        <br>
        <p  class="c4 c11"><span></span></p>
        <p  class="c4 c11"><span></span></p>
      </div>
    </div>
    </div> 
  </body>
</html>
